B and T cell responses to the 3rd and 4th dose of the BNT162b2 vaccine in dialysis patients

• Egile Nagusiak: Younes Bathish (Egilea), Neta Tuvia (Egilea), Elizabeth Eshel (Egilea), Tali Tal Lange (Egilea), Christiane Sigrid Eberhardt (Egilea), Michael Edelstein (Egilea), Kamal Abu-Jabal (Egilea)
• Formatua: Liburua
• Argitaratua: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

ABSTRACTPatients on dialysis (PoD) are at high risk of severe morbidity and mortality from COVID-19. Characterizing long-term vaccine immune responses in these patients will help optimize vaccine schedule for PoD. This study aimed to determine whether long-term humoral and B and T cell-responses pos...